BostonGene Announces Partnership with Takeda to Evaluate Immunotherapies Using AI-Powered Molecular Profiling
BostonGene Highlights Its AI-Powered Multiomics Platform at hubXchange’s Immuno-Oncology Xchange Boston 2024
BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting
BostonGene Announces Publication and Journal Cover Feature in Cancer Cell that Unveils a New Immune System Profiling Platform Stratifying Cancer Patients by Treatment Response
BostonGene Recognized as Designated Labs for the ComboMATCH Medicine Trial
BostonGene Announces Participation at the United States and Canadian Academy of Pathology 113th Annual Meeting
BostonGene Bolsters Leadership Team to Accelerate Innovation and Growth
BostonGene Announces Publication in Blood
BostonGene Named to the 2023 CB Insights' Digital Health 50 List
BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition